ZOPTEC: Phase Iii Randomized Controlled Study Comparing Zoptarelin with Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer (Nct01767155).

AuthID
 P-00V-TB7
11
Author(s)
Bondarenko, I
·
Westermann, AM
·
Oaknin, A
·
Oza, AM
·
Lisyanskaya, AS
·
Vergote, I
·
Wenham, RM
·
Temkin, SM
·
Gabra, H
Document Type
Article
Year published
2018
Published
in Journal of Clinical Oncology, ISSN: 0732-183X
Volume: 36, Issue: 15_suppl, Pages: 5503-5503
Indexing
Crossref®23
Google Scholar®
Publication Identifiers
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service